You are here

Pancreas

Pandion, Astellas sign $900m deal for pancreas-targeted immunomodulators

Pharmaceutical Business Review

Thu, 10/31/19 - 11:03 am

Pandion Therapeutics

immunomodulators

autoimmune disease

Diabetes: Progress in artificial pancreas could save Medicare nearly $1B | MassDevice.com On Call

Fri, 08/10/12 - 01:12 am

Artificial pancreas could make pregnancy safer for diabetic women

Mon, 01/31/11 - 04:33 pm